Covigilant Research, LLC Clinical Trials Site Management Organization

Covigilant Research, LLC

Committed To Working Together

FDA Approves Cabozantinib for Radioactive Iodine–Refractory Differentiated Thyroid Cancer,

Findings from the phase 3 COSMIC-311 trial led to the approval of … Center at Jefferson Torresdale Hospital; co-director, community-based clinical Trials, …, Findings from the phase 3 COSMIC-311 trial led to the approval of … Center at Jefferson Torresdale Hospital; co-director, community-based clinical Trials, …, Read More

Scroll to Top